G. Leposavic et al., Differential effects of chronic propranolol treatment on the phenotypic profile of thymocytes from immature and adult rats, IMMUNOPHARM, 46(1), 2000, pp. 79-87
To elucidate a putative role of beta-adrenoceptors in the modulation of int
rathymic T-cell maturation, the expression of major differentiational antig
ene (CD4/CD8 and TCR alpha beta) on the thymocytes from both immature (aged
21 day at the beginning of the treatment) and adult (a,oed 75 days at the
beginning of treatment) male rats subjected to a 15-day-long propranolol tr
eatment (0.40 mg/100 g/day, s.c.) was analyzed by two- and one-color flow c
ytometry, respectively. Rats of matched age injected with saline served as
controls. The propranolol treatment in immature but not adult rats caused a
significant reduction in both the relative thymus weight and total thymocy
te yield. In addition, a significant increase in the percentage of CD4(+)8(
+) double-positive cells, with a proportional decrease in the relative prop
ortion of CD4(+)8(-) single positive cells, was found in immature rats. In
contrast, a slight but significant decrease in the percentage of CD4(+)8(+)
cells with a parallel increase in the relative proportion of CD4+8- cells
was found in adult rats. In both groups of rats, the percentage of TCR alph
a beta(total) thymocytes was increased: in immature rats this was due to an
increase in the percentage of TCR alpha beta(low) thymocytes, while in the
adult rats it reflected a rise in the relative proportion of TCR alpha bet
a(high) cells. In conclusion, the study revealed that propranolol treatment
in both immature and adult rats alters the relative proportion of CD4(+)8(
+) and CD4(+)8(-) thymocytes, but in opposite fashion, and the data suggest
that this treatment affects distinct fractions within the population of CD
4(+)8(+) thymocytes with respect to expression of TCR alpha beta. The resul
ts also indicate that, regardless of rat sexual maturity, the development o
f thymocytes towards CD4(-)8(+) T-cells is relatively insensitive to long-l
asting P-adrenoceptor blockade. (C) 2000 Elsevier Science B.V. All rights r
eserved.